title: Life-threatening bullous skin eruptions during interleukin-2 therapy.
authors.affiliation: Department of Medicine, University of California, San Francisco 94143-0128.
authors.forename: M R
authors.initials: MR
authors.lastname: Staunton
authors.forename: M C
authors.initials: MC
authors.lastname: Scully
authors.forename: P E
authors.initials: PE
authors.lastname: Le Boit
authors.forename: F R
authors.initials: FR
authors.lastname: Aronson
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*
chemical_list: D000900:Anti-Bacterial Agents; D007376:Interleukin-2